Lattice Biologics Ltd. Lattice Biologics Ltd.

Lattice Biologics Ltd.

LBLTF

Rank in Stocks #34348
Lattice Biologics Ltd. is a biotechnology firm focused on developing,... Lattice Biologics Ltd. is a biotechnology firm focused on developing, manufacturing, and commercializing biological products designed for bone regeneration. These solutions are utilized globally across dental, spinal, and general orthopedic indications. The company's innovative offerings include novel amniotic fluid-based therapies such as AmnioBoost and AmnioBlast. In addition, their product line features a broad range of allografts, encompassing traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix varieties. These versatile products serve numerous critical medical applications, from enhancing spinal fusion and aiding breast reconstruction post-mastectomy to promoting bone regeneration in foot and ankle surgeries and fostering skull healing after neurosurgery. They also play a role in improving wound repair for burn victims, facilitating hernia repair, addressing subchondral bone defects in knee and other joint surgeries, and supporting various sports medicine procedures, including anterior and posterior cruciate ligament repairs. The company's headquarters are located in Belgrade, Montana.
Share Price
$0.0001
Last synced: 2026-11-19
Market Cap
$12.82K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Lattice Biologics Ltd. (LBLTF)
EPS as of June 2021 TTM: $-0.01
According to Lattice Biologics Ltd.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2020 the company had an EPS of $-0.01, equal to its 2019 EPS of $-0.01.
EPS history for Lattice Biologics Ltd. from 2001 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.01 -28.00%
2020 $-0.01 34.26%
2019 $-0.01 -18.18%
2018 $-0.01 -32.31%
2017 $-0.02 -87.81%
2016 $-0.16 6.67%
2015 $-0.15 -42.31%
2014 $-0.26 8.33%
2013 $-0.24 20.00%
2012 $-0.20 -98.54%
2011 $-13.70 1,474.71%
2010 $-0.87 335.00%
2009 $-0.20 -97.38%
2008 $-7.63 557.76%
2007 $-1.16 -11.45%
2006 $-1.31 -21.56%
2005 $-1.67 1.83%
2004 $-1.64 -11.83%
2003 $-1.86 -58.76%
2002 $-4.51 59,242.11%
2001 $-0.01 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$2.70 -37,600.00%
US
$4.09 -56,905.56%
IE
$9.45 -131,350.00%
US
$2.37 -33,016.67%
US
$1.77 -24,683.33%
US

Questions about Lattice Biologics Ltd.'s earnings per share (EPS)

What is Lattice Biologics Ltd.'s earnings per share (EPS)?

Lattice Biologics Ltd.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2021.

What was Lattice Biologics Ltd.'s earnings per share (EPS) in 2020?

In 2020, Lattice Biologics Ltd.'s earnings per share (EPS) was $-0.01, compared with $-0.01 in 2019.

How has Lattice Biologics Ltd.'s earnings per share (EPS) changed since 2015?

From 2015 to 2020, Lattice Biologics Ltd.'s earnings per share (EPS) was highest in 2020 ($-0.01) and lowest in 2016 ($-0.16).

How does Lattice Biologics Ltd.'s earnings per share (EPS) compare with similar companies?

Lattice Biologics Ltd.'s earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.